3D spheroid models and live-cell analysis are powerful tools transforming drug discovery and cancer science. Download this eBook ‘Exploring the Versatility of Using 3D Spheroid Models in Research‘ from Sartorius to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more… Read More
3D spheroid models and live-cell analysis – powerful tools transforming drug discovery and cancer science! Download the eBook to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more reliable, clinically relevant cancer models Download now and accelerate your breakthroughs. … Read More
Calluna Pharma will use Qureight’s AI-powered imaging and clinical data curation platform to support its Phase II AURORA study. Qureight will analyse imaging data from adult patients, evaluating anatomical lung changes in individuals treated with CAL101, Calluna’s lead asset for the treatment of idiopathic pulmonary fibrosis (IPF). Read More
The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More
The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More
The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More
The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More
The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA) approaches fall… Read More
A new eBook is now available for download entitled ‘Using imaging in drug discovery’. According to a January 2024 report by market analysts Coherent Market Insights, the global bio-imaging market was estimated to be worth $5.74 billion in 2023 and is poised to reach $15.58 billion… Read More
This eBook explores the important role that imaging plays in drug discovery, and how ever-evolving technologies, combined with artificial intelligence (AI), are expanding our knowledge and advancing new therapeutics to the clinic. Download this exclusive eBook to learn more about: How new imaging modalities are supporting… Read More
Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. The discovery of two genes responsible for sensing the environment and adapting cell shape could offer potential new drug targets to… Read More
Culturing cells in 3D is simply a more realistic way to model how cells move and function in vitro. Spheroids, organoids, and more complex 3D systems have been invaluable to research, drug discovery, and personalised medicine. This ebook, sponsored by Corning, offers a practical guide for demystifying spheroids and… Read More
Provider of high-performance life science solutions Molecular Devices has celebrated the one-year anniversary of its automated 3D imaging workcell, the Organoid Innovation Center with the expansion of new cell engineering capabilities. Located at the company’s global headquarters, the Organoid Innovation Center helps researchers automate sample prep… Read More
